Precigen (PGEN) Total Liabilities (2011 - 2026)
Precigen (PGEN) reported Total Liabilities of $118.4 million for Q1 2026, up 4.47% year-over-year from $113.3 million in Q1 2025, and down 12.04% quarter-over-quarter from $134.6 million in Q4 2025.
Precigen (PGEN) Total Liabilities (2011 - 2026) Analysis & Trends
Precigen (PGEN) has 16 years of Total Liabilities data on file, last reported at $118.4 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $118.4 million, up 4.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $118.4 million (up 4.47% YoY), and the FY2025 annual result was $134.6 million, up 71.38% from the prior year.
- Total Liabilities declined to $118.4 million in Q1 2026 per PGEN's latest filing, from $134.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $265.6 million in Q2 2022 and troughed at $28.1 million in Q3 2024.
- A 5-year average of $99.2 million and a median of $89.7 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities tumbled 84.44% in 2023, then jumped 360.52% in 2025.
- A 5-year view of Total Liabilities shows it stood at $89.7 million in 2022, then tumbled by 63.73% to $32.5 million in 2023, then soared by 141.31% to $78.5 million in 2024, then soared by 71.38% to $134.6 million in 2025, then retreated by 12.04% to $118.4 million in 2026.
- Business Quant data shows PGEN's Total Liabilities at $118.4 million in Q1 2026, $134.6 million in Q4 2025, and $129.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 137.56 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 118.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.39 Mn |
| Dec 31, 2025 | 134.59 Mn |
| Sep 30, 2025 | 129.40 Mn |
| Jun 30, 2025 | 107.79 Mn |
| Mar 31, 2025 | 113.33 Mn |
| Dec 31, 2024 | 78.54 Mn |
| Sep 30, 2024 | 28.10 Mn |
| Jun 30, 2024 | 29.99 Mn |
| Mar 31, 2024 | 37.83 Mn |
| Dec 31, 2023 | 32.55 Mn |
| Sep 30, 2023 | 43.01 Mn |
| Jun 30, 2023 | 41.32 Mn |
| Mar 31, 2023 | 57.41 Mn |
| Dec 31, 2022 | 89.72 Mn |
| Sep 30, 2022 | 116.71 Mn |
| Jun 30, 2022 | 265.57 Mn |
| Mar 31, 2022 | 261.73 Mn |
| Dec 31, 2021 | 252.51 Mn |
| Sep 30, 2021 | 245.65 Mn |
| Jun 30, 2021 | 243.38 Mn |